Literature DB >> 8879261

Metastasis of chondrosarcoma.

T Ozaki1, A Hillmann, N Lindner, S Blasius, W Winkelmann.   

Abstract

This study was undertaken to analyse metastases of patients with intermediate- or high-grade chondrosarcomas. Out of 24 intermediate-grade tumours, 5 (21%) developed metastases, as did 6 of 10 high-grade tumours (60%) (P = 0.04). Four patients developed pulmonary metastasis only, 5 developed both pulmonary metastases and metastases of the other sites. Two patients showed a rare metastatic pattern: bone metastases only. The metastasis rate in the primary chondrosarcoma (42%) was higher than that in the secondary chondrosarcomas (0%) (P = 0.03). The metastasis rate was higher in patients with local recurrence (86%) than in those without local recurrence (19%) (P = 0.01). In 5 of 6 patients who had a local relapse and metastasis, the interval between the two relapses was a few months.

Entities:  

Mesh:

Year:  1996        PMID: 8879261

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  13 in total

1.  Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86).

Authors:  K Winkler; S Bielack; G Delling; M Salzer-Kuntschik; R Kotz; C Greenshaw; H Jürgens; J Ritter; C Kusnierz-Glaz; R Erttmann
Journal:  Cancer       Date:  1990-10-15       Impact factor: 6.860

2.  Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading.

Authors:  H L Evans; A G Ayala; M M Romsdahl
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

3.  Case of chondrosarcoma with pulmonary and skeletal metastases after hemipelvectomy, successfully treated with 35S-sulfate.

Authors:  H Boström; B Edgren; U Friberg; K S Larsson; U Nilsonne; B Wengle; P O Wester
Journal:  Acta Orthop Scand       Date:  1968

4.  Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents.

Authors:  V Göbel; H Jürgens; G Etspüler; H Kemperdick; R M Jungblut; U Stienen; U Göbel
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 5.  Extensive skeletal metastases from chondrosarcoma without pulmonary involvement.

Authors:  D G Disler; A E Rosenberg; D Springfield; J X O'Connell; D I Rosenthal; S V Kattapuram
Journal:  Skeletal Radiol       Date:  1993-11       Impact factor: 2.199

6.  Unusual metastatic chondrosarcoma detected with bone scintigraphy.

Authors:  R Abello; F Lomeña; A Garcia; R Herranz; J Fernandez Sola; V Plaza; M Sole; J Setoain
Journal:  Eur J Nucl Med       Date:  1986

7.  A system for the surgical staging of musculoskeletal sarcoma.

Authors:  W F Enneking; S S Spanier; M A Goodman
Journal:  Clin Orthop Relat Res       Date:  1980 Nov-Dec       Impact factor: 4.176

8.  Chondrosarcoma in children and adolescents.

Authors:  H Aprin; E J Riseborough; J E Hall
Journal:  Clin Orthop Relat Res       Date:  1982-06       Impact factor: 4.176

9.  Chondrosarcoma of bone. The experience at the Istituto Ortopedico Rizzoli.

Authors:  S Gitelis; F Bertoni; P Picci; M Campanacci
Journal:  J Bone Joint Surg Am       Date:  1981-10       Impact factor: 5.284

10.  A review of the behaviour of chondrosarcoma of bone.

Authors:  N G Sanerkin; P Gallagher
Journal:  J Bone Joint Surg Br       Date:  1979-11
View more
  12 in total

1.  [Comment on the work "Therapy of enchondroma in long bones" (H. Steckel, M. Oldenburg, R.T. Müller)].

Authors:  W Mutschler; W Sienel
Journal:  Unfallchirurg       Date:  2005-06       Impact factor: 1.000

2.  Epigenetic control of cancer by neuropeptides.

Authors:  Karina Galoian; Parthik Patel
Journal:  Biomed Rep       Date:  2016-11-08

3.  Is bone scintigraphy necessary in the initial surgical staging of chondrosarcoma of bone?

Authors:  Hassan Douis; Steven L James; Robert J Grimer; Mark A Davies
Journal:  Skeletal Radiol       Date:  2011-09-03       Impact factor: 2.199

4.  Analysis of IL6-protein complexes in chondrosarcoma.

Authors:  Karina Galoian; Shihua Luo; Parthik Patel
Journal:  Biomed Rep       Date:  2017-11-10

Review 5.  Current advances in animal model of chondrosarcoma and related research.

Authors:  Yu-Xin Liao; Ying-Qi Hua; Zheng-Dong Cai
Journal:  Biomed Rep       Date:  2012-10-01

6.  Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1.

Authors:  Karina Galoian; Amir Qureshi; Gianluca D'Ippolito; Paul C Schiller; Marco Molinari; Andrea L Johnstone; Shaun P Brothers; Ana C Paz; H T Temple
Journal:  Int J Oncol       Date:  2015-06-18       Impact factor: 5.650

Review 7.  Malignant abdominal rocks: where do they come from?

Authors:  Joan M Cheng; Sree Harsha Tirumani; Kyung Won Kim; Sachin S Saboo; Juan C Baez; Atul B Shinagare
Journal:  Cancer Imaging       Date:  2013-12-11       Impact factor: 3.909

8.  Bony metastases following complete resection of periosteal chondrosarcoma.

Authors:  Xiwei Liu; Li Min; Ganjun Chen; Song Hong; Chongqi Tu
Journal:  World J Surg Oncol       Date:  2015-03-26       Impact factor: 2.754

9.  Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma.

Authors:  Karina Galoian; Silva Abrahamyan; Gor Chailyan; Amir Qureshi; Parthik Patel; Gil Metser; Alexandra Moran; Inesa Sahakyan; Narine Tumasyan; Albert Lee; Tigran Davtyan; Samvel Chailyan; Armen Galoyan
Journal:  Int J Oncol       Date:  2017-11-09       Impact factor: 5.650

Review 10.  Chondrosarcoma-from Molecular Pathology to Novel Therapies.

Authors:  Agnieszka E Zając; Sylwia Kopeć; Bartłomiej Szostakowski; Mateusz J Spałek; Michał Fiedorowicz; Elżbieta Bylina; Paulina Filipowicz; Anna Szumera-Ciećkiewicz; Andrzej Tysarowski; Anna M Czarnecka; Piotr Rutkowski
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.